385 related articles for article (PubMed ID: 12360238)
1. Genes and patent policy: rethinking intellectual property rights.
Andrews LB
Nat Rev Genet; 2002 Oct; 3(10):803-8. PubMed ID: 12360238
[TBL] [Abstract][Full Text] [Related]
2. Intellectual property and biotechnology: the U.S. internal experience--Part II.
Brody B
Kennedy Inst Ethics J; 2006 Jun; 16(2):105-28. PubMed ID: 17036443
[TBL] [Abstract][Full Text] [Related]
3. Ethico-legal issues in biomedicine patenting: a patent professional viewpoint.
Crespi RS
Sci Eng Ethics; 2005 Jan; 11(1):117-36. PubMed ID: 15727007
[TBL] [Abstract][Full Text] [Related]
4. Bioterrorism and patent rights: "compulsory licensure" and the case of Cipro.
Resnik DB; DeVille KA
Am J Bioeth; 2002; 2(3):29-39. PubMed ID: 12230852
[No Abstract] [Full Text] [Related]
5. Ethical reasons for narrowing the scope of biotech patents.
Andreassen T
Med Health Care Philos; 2015 Nov; 18(4):463-73. PubMed ID: 25968142
[TBL] [Abstract][Full Text] [Related]
6. Gene patents: the need for bioethics scrutiny and legal change.
Andrews LB; Paradise J
Yale J Health Policy Law Ethics; 2005; 5(1):403-12. PubMed ID: 15742584
[No Abstract] [Full Text] [Related]
7. Intellectual property and biotechnology: the U.S. internal experience--Part I.
Brody B
Kennedy Inst Ethics J; 2006 Mar; 16(1):1-37. PubMed ID: 16770885
[TBL] [Abstract][Full Text] [Related]
8. The scope of utility in the twenty-first century: new guidance for gene-related patents.
Summers TM
Georgetown Law J; 2003 Jan; 91(2):475-509. PubMed ID: 15046071
[No Abstract] [Full Text] [Related]
9. Patent first, ask questions later: morality and biotechnology in patent law.
Bagley MA
William Mary Law Rev; 2003 Dec; 45(2):469-547. PubMed ID: 15570677
[TBL] [Abstract][Full Text] [Related]
10. Patent prosecution strategies for biotechnological inventions.
Yeh JJ; Fernandez D
Assay Drug Dev Technol; 2004 Dec; 2(6):697-702. PubMed ID: 15674028
[TBL] [Abstract][Full Text] [Related]
11. Challenges to human embryonic stem cell patents.
Plomer A; Taymor KS; Scott CT
Cell Stem Cell; 2008 Jan; 2(1):13-7. PubMed ID: 18371416
[TBL] [Abstract][Full Text] [Related]
12. Intellectual property rights in genes and gene fragments: a registration solution for expressed sequence tags.
Holman MA; Munzer SR
Iowa Law Rev; 2000 Mar; 85(3):735-848. PubMed ID: 16523593
[No Abstract] [Full Text] [Related]
13. Patenting Foundational Technologies: Lessons From CRISPR and Other Core Biotechnologies.
Feeney O; Cockbain J; Morrison M; Diependaele L; Van Assche K; Sterckx S
Am J Bioeth; 2018 Dec; 18(12):36-48. PubMed ID: 31159699
[TBL] [Abstract][Full Text] [Related]
14. Biomedical patents and ethics: a Canadian solution.
Gold ER
McGill Law J; 2000 May; 45(2):413-35. PubMed ID: 12688288
[TBL] [Abstract][Full Text] [Related]
15. The two meanings of how and the gene patenting debate.
Evans JH
Am J Bioeth; 2002; 2(3):26-8. PubMed ID: 12230851
[No Abstract] [Full Text] [Related]
16. Intellectual property and products of nature.
Sagoff M
Am J Bioeth; 2002; 2(3):12-3. PubMed ID: 12230841
[No Abstract] [Full Text] [Related]
17. How can you patent genes?
Eisenberg RS
Am J Bioeth; 2002; 2(3):3-11. PubMed ID: 12230840
[TBL] [Abstract][Full Text] [Related]
18. Locating gene patents within the patent system.
Rai AK
Am J Bioeth; 2002; 2(3):18-9. PubMed ID: 12230845
[No Abstract] [Full Text] [Related]
19. DNA patents and human dignity.
Resnik DB
J Law Med Ethics; 2001; 29(2):152-65. PubMed ID: 11508191
[No Abstract] [Full Text] [Related]
20. The morality of biotech patents: differing legal obligations in Europe?
Ford R
Eur Intellect Prop Rev; 1997 Jun; 19(6):315-8. PubMed ID: 16538738
[No Abstract] [Full Text] [Related]
[Next] [New Search]
